Naveen S. Basappa

Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study

Toni K. Choueiri, Masatoshi Eto, Robert J. Motzer et al. · The Lancet Oncology · 2023 · 149 citations · Full text

Pembrolizumab Versus Sunitinib, Urology, Genitourinary Cancer +8

Gastric Acid Suppression Is Associated With Decreased Erlotinib Efficacy in Non–Small-Cell Lung Cancer

Michael P. Chu, Sunita Ghosh, Carole Chambers et al. · Clinical Lung Cancer · 2014 · 101 citations

Decreased Erlotinib Efficacy, Non–small-cell Lung Cancer, Oncology +7

Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

Steven Yip, J. Connor Wells, Raphael Brandão Moreira et al. · Cancer · 2018 · 66 citations · Full text

Hydroxychloroquine is a safe and effective steroid-sparing agent for immune checkpoint inhibitor–induced inflammatory arthritis

Janet Roberts, Michael Smylie, John Walker et al. · Clinical Rheumatology · 2019 · 63 citations

Inflammation, Rheumatology, Immune Checkpoint +9

Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma

Bimal Bhindi, Jeffrey Graham, J. Connor Wells et al. · European Urology · 2020 · 60 citations

Urology, Surgical Oncology, Genitourinary Cancer +6